Institute For Cancer Research
- Assets
- $148.1m
- Revenue
- $82.6m
- Investments
- $0.0
- Employees
- 712
- Location
- Philadelphia, PA
- Founding
- 12/1944
- Data as of
- 06/2021
- EIN
- 23-6296135
Organization Overview
Institute For Cancer Research is located in Philadelphia, PA. The organization was established in 1944. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. As of 06/2021, Institute For Cancer Research employed 712 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Institute For Cancer Research is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Institute For Cancer Research generated $82.6m in total revenue. The organization has seen a slow decline revenue. Over the past 6 years, revenues have fallen by an average of (0.4%) each year. All expenses for the organization totaled $82.7m during the year ending 06/2021. You can explore the organizations financials more deeply in the financial statements section below.
Since 2016, Institute For Cancer Research has awarded 12 individual grants totaling $6,588,668. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE INSTITUTE FOR CANCER RESEARCH AND ITS RESEARCH PROGRAMS ARE RENOWNED WORLD-WIDE FOR THEIR WORK IN UNDERSTANDING BOTH NORMAL AND ABNORMAL CELL GROWTH. SCIENTISTS ARE INVOLVED IN STUDIES OF GENES THAT CAUSE OR INHIBIT CANCER GROWTH, VIROLOGY, IMMUNOLOGY, CHEMICAL CARCINOGENS, CELL GROWTH AND INTERACTION AND GENE EXPRESSION. IN RECENT YEARS, RESEARCH HAS INCREASINGLY EMPHASIZED MOLECULAR ONCOLOGY AND GENETICS, AREAS WHICH BRIDGE ADVANCING KNOWLEDGE FROM THE LABORATORY WITH NEW CLINICAL APPROACHES.
THE RESEARCH FACILITIES HAVE BEEN STRUCTURED TO FULFILL THE NEEDS OF THE MULTI-DISCIPLINARY RESEARCH PROGRAMS AT FOX CHASE CANCER CENTER. THE FACILITIES HAVE BEEN DESIGNED TO ENHANCE ONGOING RESEARCH BY SUPPLYING INFORMATION, REAGENTS, AND TECHNICAL EXPERTISE THAT ARE NOT READILY AVAILABLE TO THE INDIVIDUAL INVESTIGATOR.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jonathan Chernoff Chief Science Officer | 50 | $450,609 | |
Dr J Robert Beck Chief Academic Officer | Officer | 46 | $427,870 |
Michael Hall Professor | 50 | $420,350 | |
Mary Daly Chair Clinical Genetics | 50 | $326,320 | |
Shawn Paul Kleitz Chief Development Officer | 50 | $325,897 | |
Jose Russo Director Of The Fox Chase Breast Cancer Research L | 50 | $314,328 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
American Oncologic Hospital Purchased Services | 6/29/21 | $6,116,926 |
Temple Faculty Practice Plan Purchased Services | 6/29/21 | $869,930 |
Temple University University Health Syst Purchased Services | 6/29/21 | $1,899,730 |
Illumina Inc Purchased Services | 6/29/21 | $183,150 |
Southampton Window Cleanng & Janitorial Purchased Services | 6/29/21 | $168,503 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $26,343,794 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $4,911,749 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $31,255,543 |
| Total Program Service Revenue | $46,663,620 |
| Investment income | $4,430,931 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $225,384 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $924 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $82,576,402 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $701,224 |
| Grants and other assistance to domestic individuals. | $426,384 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $462,047 |
| Compensation of current officers, directors, key employees. | $462,047 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $45,026,703 |
| Pension plan accruals and contributions | $2,252,590 |
| Other employee benefits | $8,252,284 |
| Payroll taxes | $2,975,464 |
| Fees for services: Management | $295,444 |
| Fees for services: Legal | $22,955 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $6,866 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $1,963,641 |
| Advertising and promotion | $0 |
| Office expenses | $1,508,277 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $3,113,253 |
| Travel | $61,160 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $30,889 |
| Interest | $1,070,100 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $2,757,612 |
| Insurance | $60,342 |
| All other expenses | $0 |
| Total functional expenses | $82,749,706 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,989,151 |
| Savings and temporary cash investments | $441,267 |
| Pledges and grants receivable | $10,498,571 |
| Accounts receivable, net | $3,011,869 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $921,948 |
| Net Land, buildings, and equipment | $22,238,951 |
| Investments—publicly traded securities | $7,553,699 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $2,061,022 |
| Other assets | $99,420,763 |
| Total assets | $148,137,241 |
| Accounts payable and accrued expenses | $19,246,458 |
| Grants payable | $3,664,236 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $614,230 |
| Other liabilities | $21,865,733 |
| Total liabilities | $45,390,657 |
| Net assets without donor restrictions | $7,910,940 |
| Net assets with donor restrictions | $94,835,644 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $148,137,241 |
Grants Awarded
Over the last fiscal year, Institute For Cancer Research has awarded $2,086,184 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
Philadelphia, PA PURPOSE: General Support | $550,417 |
Philadelphia, PA PURPOSE: General Support | $550,417 |
Philadelphia, PA PURPOSE: General Support | $492,675 |
Philadelphia, PA PURPOSE: General Support | $492,675 |
Grants Recieved
Over the last fiscal year, we have identified 12 grants that Institute For Cancer Research has recieved totaling $1,358,011.
| Awarding Organization | Amount |
|---|---|
The V Foundation Cary, NC PURPOSE: CANCER RESEARCH | $400,000 |
American Cancer Society Inc Kennesaw, GA PURPOSE: Extramural Research Grant | $250,500 |
Prevent Cancer Foundation Alexandria, VA PURPOSE: Support for research. | $200,000 |
Kidney Cancer Association Houston, TX PURPOSE: KIDNEY CANCER RESEARCH - TRAILBLAZER AWARD & PSYCHOSOCIAL AWARD | $150,000 |
Conquer Cancer Fdn Of The American Society Of Clinical Oncology Alexandria, VA PURPOSE: YIA | $100,000 |
Wawa Foundation Inc Wawa, PA PURPOSE: TO SUPPORT THE FOUNDATION PROGRAM INITIATIVES | $70,000 |
Endowment Analysis
| Beg. Balance | $15,798,493 |
| Earnings | $2,215,582 |
| Admin Expense | $3,321 |
| Net Contributions | -$1,006,979 |
| Other Expense | $2,740,895 |
| Ending Balance | $14,262,879 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Ludwig Institute For Cancer Research New York, NY | $25,811,385 | $89,264,708 |
Institute For Cancer Research Philadelphia, PA | $148,137,241 | $82,576,402 |
Wistar Institute Of Anatomy & Biology Philadelphia, PA | $414,460,000 | $115,831,000 |
American Association For Cancer Research Philadelphia, PA | $261,131,206 | $103,171,549 |
The Gog Foundation Inc Edgewater, MD | $96,851,330 | $51,133,816 |
Nsabp Foundation Inc Pittsburgh, PA | $90,333,934 | $55,869,172 |
Cancer Research Institute Inc New York, NY | $130,438,312 | $33,675,150 |
Centre County Cancer Center State College, PA | $6,772,389 | $27,589,392 |
Nrg Oncology Foundation Inc Philadelphia, PA | $13,392,636 | $27,206,954 |
Cancer Research America Nfcr Inc Rockville, MD | $12,283,856 | $11,465,290 |
Premier Community Health Dayton, OH | $3,886,537 | $6,142,148 |
Abraham J And Phyllis Katz Cord Blood Foundation Cleveland, OH | $4,596,233 | $6,882,274 |